No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration with emtricitabine/tenofovir-DF has not been studied but based on metabolism and clearance a clinically significant interaction is unlikely. Coadministration of fostemsavir and tenofovir-DF had no significant effect on temsavir pharmacokinetics, but increased tenofovir Cmax, AUC and Cmin by 18%, 19% and 28%. These changes were not considered to be clinically relevant. No interaction is expected with emtricitabine.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking